- Home
- HBAN vs CNC Comparison
HBAN vs CNC Comparison
Compare HBAN & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HBAN | CNC |
|---|---|---|
| Founded | 1866 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3B | 34.0B |
| IPO Year | 2010 | 2001 |
Fundamental Metrics
Financial Performance| Metric | HBAN | CNC |
|---|---|---|
| Price | $15.72 | $70.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 21 |
| Target Price | $19.17 | ★ $71.78 |
| AVG Volume (30 Days) | ★ 24.4M | 3.1M |
| Earning Date | 10-22-2026 | 10-27-2026 |
| Dividend Yield | ★ 3.96% | N/A |
| EPS Growth | ★ 13.93 | N/A |
| EPS | 0.25 | ★ 5.30 |
| Revenue | $1,562,000,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $35.51 | $11.28 |
| Revenue Next Year | $7.09 | N/A |
| P/E Ratio | $62.70 | ★ $13.45 |
| Revenue Growth | 6.40 | ★ 19.44 |
| 52 Week Low | $14.82 | $31.63 |
| 52 Week High | $19.44 | $72.50 |
Technical Indicators
Market Signals| Indicator | HBAN | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 52.24 | 61.33 |
| Support Level | $14.95 | $63.36 |
| Resistance Level | $17.25 | N/A |
| Average True Range (ATR) | 0.30 | 2.15 |
| MACD | 0.11 | 0.49 |
| Stochastic Oscillator | 83.51 | 75.68 |
Price Performance
Historical ComparisonAbout HBAN Huntington Bancshares Incorporated
Huntington is a regional US bank with over $285 billion in assets. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.